Ticker AGTC – Applied Genetic – sales, description, marketcap – Tickerday.com

AGTC

Applied Genetic

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 128.77M; Volume: 61.87K; AvgVol 3m: 318.32K; Beta: 2.47;

Cost estimate:

P/E: –; EPS: -2.17; EPS growth quarter/prev quarter: 2.50%;

EPS growth this year: 7.80%; EPS growth past 5 years: -7.80%;

EPS ttm: -2.18;

P/S: 56.76; P/B: 1.96; P/Cashflow: 1.76; P/FCF: ;

Sales: 2.45M; Sales growth quarter/prev quarter: -100.00%; Sales growth past 5 years: 0.80%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -49.30%; ROE – return on equity: -64.70%; LT Debt/Equity: 0.14; Total Debt/Equity: 0.14;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.30%; Insider Transactions:0.00%;

Institutional Ownership: 77.80%; Institutional Transactions: 8.96%;

Data update: 07/10/2020.